丹參酮I
分析標(biāo)準(zhǔn)品,HPLC≥98%
Tanshinone I
CAS號：568-73-0
分子式：C18H12O3
分子量：276.29
MDL：MFCD00210563
貨號 | 規(guī)格/參數(shù)/品牌 | 價格 | 貨期 |
YJ-B20256-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥300.00 | 現(xiàn)貨 |
YJ-B20256-200mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1180.00 | 現(xiàn)貨 |
JS31643-100mg | ≥96%(HPLC) | ￥465.00 | 現(xiàn)貨 |
JS31643-500mg | ≥96%(HPLC) | ￥1240.00 | 現(xiàn)貨 |
JS31643-1g | ≥96%(HPLC) | ￥2100.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點：233-234℃
沸點：498℃ at 760 mmHg
外觀：棕紅色結(jié)晶
溶解性：DMSO：2mg/ml
敏感性：對光敏感
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(44篇)
44. [IF=10.2] Chenjie Xia et al."An efficient brain delivery system co-loaded with multiple components of Salvia miltiorrhiza for synergistic treatment of ischemic stroke."Materials Today Bio.2025 Jul;:102102
43. [IF=3.4] Wang Qiaona et al."Anti-oxidative effect of Salvia miltiorrhiza Bunge fermented with Shiraia bambusicola Henn. against H2O2-induced injury in PC12 cells."BMC Complementary Medicine and Therapies.2025 Dec;25(1):1-13
42. [IF=4] Lijuan Wu et al."Integration of chromatographic fractionation, quantitative 1H-NMR and serially coupled achiral-chiral LC–MS/MS enables multi-components-targeted determination of Salvia miltiorrhiza in an authentic compound-independent manner."JOURNAL OF
41. [IF=4.9] Kewei Zuo et al."Transcriptome- and Metabolome-Based Regulation of Growth, Development, and Bioactive Compounds in Salvia miltiorrhiza (Lamiaceae) Seedlings by Different Phosphorus Levels."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(13):6253
40. [IF=8.3] Liyuan Ke et al."Tanshinone I alleviates post-ischemic myocardial injury by targeting TGFBR1 and modulating the TGF-β signaling pathway."PHYTOMEDICINE.2025 Jun;:156994
39. [IF=3.8] Liping Zhang et al."Comprehensive characterization of active components in Salvia miltiorrhiza using polarity-partitioned two-dimensional liquid chromatography coupled with mass spectrometry."JOURNAL OF CHROMATOGRAPHY A.2024 Oct;:465424
38. [IF=5.7] Xue-Zhang et al."Discovery of Tetrahydro Tanshinone I as a Naturally Occurring Covalent Pan-Inhibitor Against Gut Microbial Bile Salt Hydrolases."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2024;XXXX(XXX):XXX-XXX
37. [IF=11.4] Keqin Lu et al."Synergistic potentiation of the anti-metastatic effect of a Ginseng-Salvia miltiorrhiza herbal pair and its biological ingredients via the suppression of CD62E-dependent neutrophil infiltration and NET formation."Journal of Advanced Resear
36. [IF=8.3] Ruiyan Zhu et al."Abscisic acid enhances SmAPK1-mediated phosphorylation of SmbZIP4 to positively regulate tanshinone biosynthesis in Salvia miltiorrhiza."NEW PHYTOLOGIST.2024 Nov;:
35. [IF=8.1] Sheng Wang et al."Target-oriented rational design of composite bio-derived solvents for the green extraction of salvianolic acid B and tanshinones from Salvia miltiorrhiza root."SEPARATION AND PURIFICATION TECHNOLOGY.2025 Jun;359:130772
34. [IF=4.9] Yanbing Pan et al."Simultaneous detection of tanshinone I and cryptotanshinone using a carbon fiber microelectrode based on gold–palladium composite network."MICROCHEMICAL JOURNAL.2025 Mar;:113378
33. [IF=8.3] Cheng Jiang et al."A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity."ACS Applied Materials & Interfaces.2024;16(32):41828–41842
32. [IF=4.8] Zhengchao Ji et al."Holistic quality assessment and monitoring of YiXinShu capsule based on three-dimensional fingerprints combined with quantitative analysis, antioxidant activity and chemometrics."JOURNAL OF ETHNOPHARMACOLOGY.2024 Dec;335:118630
31. [IF=3.1] Miao Wang et al."Tanshinone IIA, originated from Salvia miltiorrhiza, activated EPO/EPOR-JAK2-STAT5 pathway in rat blood deficiency therapy."SOUTH AFRICAN JOURNAL OF BOTANY".2024 Jul;170:105
30. [IF=1.1] Ji-Yong FU et al."Simultaneous determination of 19 constituents in the Jian-Nao-Ning mixture using high-performance liquid chromatography-tandem mass spectrometry."Separation Science Plus".2024 Feb;:2300222
29. [IF=4.6] Yun Zhang et al."G-Quadruplexes Formation by the C9orf72 Nucleotide Repeat Expansion d(GGGGCC)n and Conformation Regulation by Fangchinoline."MOLECULES.2023 Jan;28(12):4671
28. [IF=6.388] Wei Liu et al."Tanshinone IIA relieves arthritis by inhibiting autophagy of fibroblast-like synoviocytes via matrix metalloproteinase9/receptor for advanced glycation end product/toll-like receptor 9 signal axis in mice with collagen-induced arthritis."PH
27. [IF=6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396
26. [IF=6.208] Huan Zhao et al."Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(23):15180
25. [IF=6.317] Ping Huang et al."Optimization of smashing tissue and ultrasonic extraction of tanshinones and their neuroprotective effect on cerebral ischemia/reperfusion injury by inhibiting parthanatos."Food & Function.2022 Aug;:
24. [IF=7.376] Chengtao Sun et al."Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation."Free Radical Bio Med. 2022 Feb;180:220
23. [IF=6.057] Qi Tong et al.Biosynthesis-based spatial metabolome of Salvia miltiorrhiza Bunge by combining metabolomics approaches with mass spectrometry-imaging.Talanta. 2021 Nov;:123045
22. [IF=2.1] Yuyan Zhang et al."Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression."Mol Med Rep. 2021 Jan;23(1):1-1
21. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950
20. [IF=3.411] Liu Hongyan et al."Effect Study of Continuous Monoculture on the Quality of Salvia miltiorrhiza Bge Roots."Biomed Res Int. 2020;2020:4284385
19. [IF=3.69] Qian Zhang et al."Qishen Granule alleviates endoplasmic reticulum stress-induced myocardial apoptosis through IRE-1-CRYAB pathway in myocardial ischemia."J Ethnopharmacol. 2020 Apr;252:112573
18. [IF=3.935] Zhengchao Ji et al."Global identification and quantitative analysis of representative components of Xin-Nao-Kang Capsule, a traditional Chinese medicinal formula, by UHPLC-Q-TOF-MS and UHPLC-TQ-MS."J Pharmaceut Biomed. 2021 May;198:114002
17. [IF=4.411] Yuanyuan Li et al."Quantitative Determination and Validation of Four Ketones in Salvia miltiorrhiza Bunge Using Quantitative Proton Nuclear Magnetic Resonance Spectroscopy."Molecules. 2020 Jan;25(9):2043
16. [IF=6.475] Shi Qiu et al."Selection of appropriate post-harvest processing methods based on the metabolomics analysis of Salvia miltiorrhiza Bunge."Food Res Int. 2021 Jun;144:110366
15. [IF=7.514] Tong Wang et al."A hydrophobic deep eutectic solvents-based integrated method for efficient and green extraction and recovery of natural products from Rosmarinus officinalis leaves, Ginkgo biloba leaves and Salvia miltiorrhiza roots."Food Chem. 2021 Nov;3
14. [IF=3.414] Yu-xiang Fei et al."Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats."J Ethnopharmacol. 2017 Jul;207:57
13. [IF=3.645] Yang Wang et al."Identification of Salvia species using high-performance liquid chromatography combined with chemical pattern recognition analysis."J Sep Sci. 2018 Feb;41(3):609-617
12. [IF=7.514] Tiehua Zhang et al."In vitro and in silico perspectives on estrogenicity of tanshinones from Salvia miltiorrhiza."Food Chem. 2019 Jan;270:281
11. Wang, Yang, et al. "Identification of Salvia species using high‐performance liquid chromatography combined with chemical pattern recognition analysis." Journal of separation science 41.3 (2018): 609-617.https:##doi.org/10.1002/jssc.201701066
10. 崔偉亮. 丹參酒炙前后HPLC指紋圖譜色譜峰歸屬比較[J]. 遼寧中醫(yī)雜志, v.46;No.507(08):1707-1709.
9. 王蕓, 陳軍峰, 張磊,等. 基于"有效成分-性狀"的關(guān)聯(lián)分析評價丹參品質(zhì)的研究[J]. 世界科學(xué)技術(shù):中醫(yī)藥現(xiàn)代化, 2019(5):835-843.
8. 李清清 張繼芬. 冠心寧中14種成分的含量測定[J]. 蘇鹽科技 2019 046(006):33-35.
7. 閆妍 石磊 史寧 郭宏舉 耿帥 溫彬宇.UPLC-Q-TOF-MS同時測定天王補(bǔ)心片中丹參的主要成分[J].解放軍藥學(xué)學(xué)報 2018 34(01):55-57.
6. 張玉, 戚瑩雪, 王蕾,等. 山東丹參脂溶性成分的地域分布特點研究[J]. 中藥材, 2018, 041(011):2522-2526.
5. 張芮乾,吳曉毅,胡添源,宋雅迪,高偉,黃璐琦.基于丹參酮類化合物生源途徑的丹參質(zhì)量標(biāo)志物研究思路探討[J].中國中藥雜志,2020,45(13):3098-3103.
4. 孫錦 林力 彭勍 等. 不同濃度乙醇提取丹參中12種成分比較研究[J]. 中國中醫(yī)藥信息雜志 2019(9).
3. 程沛, 韓東岐, 胡偉慧,等. 高效液相色譜法同時測定丹參中10種水溶性和4種脂溶性成分的含量[J]. 藥物分析雜志, 2015(06):991-996.
2. 胡偉慧 韓東岐 江坤 等. RP-HPLC法同時測定甘西鼠#*尾草中12種成分的含量[J]. 藥物分析雜志 2016 v.36(03):486-493.
1. 李曉梅, 秦桂美. 蘆薈-丹參復(fù)方凝膠對痤瘡主要致病菌的體外抑菌研究[J]. 中國醫(yī)學(xué)創(chuàng)新, 2014, 000(026):104-106.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實驗技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實驗服務(wù)及論文潤色十多年，是您值得信賴的科研合作伙伴!
如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實驗技術(shù)服務(wù)：
| |||
| |||
| |||
| |||
| |||
|
